Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 74

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 74
---
 the Company files any amendment thereof or supplement thereto with the SEC) or the omission
or alleged omission to state therein any material fact necessary to make the statements made therein, in light of the circumstances under
which the statements therein were made, not misleading, (iii) any violation or alleged violation by the Company of the Securities Act,
the Exchange Act, any other law, including, without limitation, any state securities law, or any rule or regulation thereunder relating
to the offer or sale of the Registrable Securities pursuant to the Registration Statement or any New Registration Statement not due to
any misrepresentation or breach under this Agreement or the Purchase AGreement by the Investor or (iv) any material violation by the Company
of this Agreement (the matters in the foregoing clauses (i) through (iv) being, collectively, “”). Subject
to Section 6(c), the Company shall reimburse each Indemnified Person promptly as such expenses are incurred and are due and payable, for
any reasonable and documented legal fees or other reasonable expenses incurred by them in connection with investigating or defending any
such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this :
(i) shall not apply to a Claim by an Indemnified Person arising out of or based upon a Violation which occurs in reliance upon and in
conformity with information about the Investor furnished in writing to the Company by such Indemnified Person expressly for use in connection
with the preparation of the Registration Statement, any New Registration Statement or any such amendment thereof or supplement thereto
or prospectus contained therein, if such Registration Statement, New Registration Statement or amendment thereof or supplement thereof
or prospectus contained therein was timely made available by the Company pursuant to ) or ; (ii)
with respect to any superseded prospectus, shall not inure to the benefit of any such Person from whom the Person asserting any such Claim
purchased the Registrable Securities that are the subject thereof (or to the benefit of any Person controlling such Person) if the untrue
statement or omission of material fact contained in the superseded prospectus was corrected in the revised prospectus, as then amended
or supplemented, if such revised prospectus was timely made available by the Company pursuant to or ,
and the Indemnified Person was promptly advised in writing not to use the incorrect prospectus prior to the use giving rise to a violation
and such Indemnified Person, notwithstanding such advice, used it; (iii) shall